1 | ||||||
|---|---|---|---|---|---|---|
2 | ||||||
3 | DHUnplugged - Pot Stocks | |||||
5 | Ticker | Name | 8/28/2018 Price | Last Price | Change From 8/28/2018 | |
6 | CGC | Canopy Growth Corp | 43.20 | 30.82 | -28.66% | |
7 | CRON | Cronos Group Inc | 11.08 | 11.38 | 2.71% | |
8 | ACBFF | #N/A | #REF! | #N/A | #N/A | |
9 | GWPH | GW Pharmaceuticals PLC- ADR | 146.17 | 120.86 | -17.32% | |
10 | CNTTF | CannTrust Holdings Inc | 7.03 | 5.54 | -21.19% | |
11 | TGODF | Green Organic Dutchman Holdings Ltd | 4.30 | 2.17 | -49.53% | |
12 | EMHTF | Emerald Health Therapeutics Inc | 3.12 | 2.00 | -35.90% | |
13 | HYYDF | Hexo Corp | 4.16 | 3.75 | -9.86% | |
14 | CBWTF | Auxly Cannabis Group Inc | 0.80 | 0.59 | -26.25% | |
15 | OGRMF | OrganiGram Holdings Inc | 4.72 | 3.50 | -25.85% | |
16 | CRBP | Corbus Pharmaceuticals Holdings Inc | 5.40 | 6.63 | 22.78% | |
17 | TRSSF | Terrascend Corp | 3.96 | 4.45 | 12.37% | |
18 | TLRY | Tilray Inc | 51.50 | 75.52 | 46.64% | |
19 | NWKRF | Newstrike Brands Ltd | 0.58 | 0.31 | -46.55% | |
20 | CNGGF | Cann Group Ltd | 2.09 | 1.50 | -28.23% | |
21 | INSY | Insys Therapeutics Inc | 7.98 | 4.93 | -38.22% | |
22 | SPRWF | Supreme Cannabis Company Inc | 1.41 | 1.05 | -25.53% | |
23 | CARA | Cara Therapeutics Inc | 19.62 | 14.08 | -28.24% | |
24 | HKG:0336 | Huabao International Holdings Limited | 4.68 | 3.30 | -29.49% | |
25 | MO | Altria Group Inc | 58.45 | 53.92 | -7.75% | |
26 | ARNA | Arena Pharmaceuticals, Inc. | 37.84 | 42.56 | 12.47% | |
27 | BIT:GIMA | Gima TT SpA | 12.61 | 6.63 | -47.42% | |
28 | TPB | Turning Point Brands Inc | 33.55 | 29.80 | -11.18% | |
29 | CPH:STG | Scandinavian Tobacco Group A/S | 101.60 | 86.85 | -14.52% | |
30 | SWM | Schweitzer-Mauduit International, Inc. | 40.89 | 26.68 | -34.75% | |
31 | CPH:SWMA | Swedish Match AB | 484.00 | 371.10 | -23.33% | |
32 | JAPAF | Japan Tobacco Inc | 26.87 | 24.98 | -7.03% | |
33 | SMG | Scotts Miracle-Gro Co | 74.00 | 65.08 | -12.05% | |
34 | IMBBY | Imperial Tobacco Group plc Sponsored ADR | 35.82 | 30.36 | -15.24% | |
35 | XXII | 22nd Century Group Inc | 2.47 | 2.66 | 7.69% | |
36 | BTI | British American Tobacco PLC | 50.02 | 33.94 | -32.15% | |
37 | PM | Philip Morris International Inc. | 79.50 | 84.34 | 6.09% | |
38 | UVV | Universal Corp | 59.45 | 63.50 | 6.81% | |
39 | IGC | India Capital Growth Fund Ltd | 99.25 | 82.40 | -16.98% | |
40 | VVCIF | VIVO Cannabis Inc | 1.14 | 0.61 | -46.49% | |
41 | VGR | Vector Group Ltd | 14.87 | 10.91 | -26.63% | |
42 | BME:MCM | Miquel y Costas & Miquel SA | 33.10 | 16.40 | -50.45% | |
43 | RDDTF | Radient Technologies Inc | 0.73 | 0.59 | -19.18% | |
44 | ||||||
45 | MJ | ETFMG Alternative Harvest ETF | 32.54 | 27.45 | -15.64% | |
46 | ||||||
47 | This is not a recommendation to buy or sell any security. Horowitz & Company clients may own shares of companies mentioned. Past performance is no indication of future results. Please research on your own or with your financial advisor. The information presented is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor otherwise. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing. | |||||
48 | ||||||
49 | SEE IMPORTANT DISCLOSURES | |||||